Investigators showed that inhibiting serpinB13, a cathepsin L protease inhibitor expressed in the pancreatic epithelium, caused in vitro and in vivo cleavage of the extracellular domain of Notch1.
[Science Translational Medicine]
Kryvalap, Y., Jiang, M. L., Kryvalap, N., Hendrickson, C., & Czyzyk, J. (2021). SerpinB13 antibodies promote β cell development and resistance to type 1 diabetes. Science Translational Medicine, 13(588). https://doi.org/10.1126/scitranslmed.abf1587 Cite
0